Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
What clinical features in suspected ANOCA push you toward proceeding directly to invasive coronary function testing rather than empirically escalating antianginal therapy first?
Related Questions
What would be your percutaneous approach to a severely stenotic bifurcation lesion with a large aneurysm post-stenosis?
When is a reasonable amount of time for patients to be on 90 mg BID of ticagrelor before transitioning to 60 mg BID following PCI?
Do you prefer the routine use of bivalirudin over UFH during PCI cases in patients presenting with ACS?
What are your top takeaways from the updated ACS guidelines that will inform changes in clinical practice?
What is your preferred intervention for diffuse severe ISR involving two layers of stent?
How do you manage anticoagulation/antiplatelet therapies with strong indications for uninterrupted therapy in setting of urgent procedures?
Do you avoid high-potency P2Y12 inhibitors in favor of clopidogrel in patients with atrial fibrillation on a DOAC who undergo PCI?
What is a reasonable protocol for how long to hold warfarin and/or DOACs before cardiac catheterization?
Would acute-onset thrombocytopenia and concern for active bleeding with platelet count below 50,000 prompt you to hold plavix and/or aspirin following PCI that was done 1-2 weeks ago?
How do the results of CREST-2 influence your recommendations on screening for asymptomatic carotid stenosis?
